BLBo Liu

Bo Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bo Liu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Ling Zhao

    Center of Reproductive Medicine, First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi

    8 shared publications
  • Chuyu Peng

    Center of Reproductive Medicine, First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi

    6 shared publications
  • Shanshan Ou

    Center of Reproductive Medicine, First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi

    5 shared publications
  • Aiping Qin

    Reproductive Medicine Research Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, China

    4 shared publications
  • Liumei Luo

    Center of Reproductive Medicine, First Affiliated Hospital of Guangxi Medical University , Nanning, Guangxi

    3 shared publications
  • Saiqiong Chen

    Guangxi Med Univ, Affiliated Hosp 4, Dept Obstet & Gynecol, Liuzhou 545005, Guangxi, Peoples R China

    3 shared publications

Latest Publications

  • Relationships between morphological score changes during embryonic development and pregnancy outcomes

    by Qiuying Gan, Wenhong Ma, Lidan Liu, Qianyi Huang, Fang Lu, Lang Qin, Liang Ren, Zhibing Deng, Chao Yang, Bo Liu, et al.

    Objective: This study investigated whether changes in embryonic morphological scores can predict pregnancy outcomes to support optimal blastocyst selection.Methods: This retrospective dual-center study analyzed 1,492 single blastocyst transfers. Blastocysts were categorized according to day 3 and day 5 scores (excellent, good, or poor) and their day 3–5 morphological changes (improvement, stability, or deterioration). The primary outcomes were clinical pregnancy rate (CPR) and live birth rate (LBR).Results: No statistically significant differences were observed in CPR or LBR among the Excellent-D3, Good-D3, and Poor-D3 embryo-quality groups. However, both CPR and LBR were significantly higher in the Excellent-D5 group compared with the Poor-D5 group (CPR: 58.64% vs. 46.34%, p=0.014; LBR: 45.97% vs. 33.54%, p=0.012). Temporal trends in developmental outcomes from day 3 to day 5 showed no significant differences across the improvement, stability, and deterioration groups for either CPR (57.95%, 55.28%, and 55.87%; p=0.615) or LBR (43.74%, 44.54%, and 40.84%; p=0.648). In stratified analysis, Poor-D3 embryos that reached Excellent-D5 status had a significantly lower LBR than Excellent-D5 embryos (40.52% vs. 48.81%: odds ratio, 0.714; 95% confidence interval, 0.513 to 0.994; p=0.046). No other subgroup comparisons demonstrated significant differences in clinical outcomes.Conclusion: Day 5 morphology is the primary predictor of CPR and LBR, with Excellent-D5 embryos demonstrating superior outcomes. Although day 3–5 morphological changes were not associated with CPR or LBR, day 3 quality contributed supplemental predictive value for distinguishing among top-tier day 5 embryos, thereby aiding embryo selection.

  • Mifepristone reduces serum cancer antigen 125 and prolactin levels to improve pregnancy rates in uterine adenomyosis mouse models

    by Chuyu Peng, Yan Zeng, Ling Zhao, Zhenqin Gao, Liumei Luo, Shanshan Ou, Yingdan Huang, Bo Liu

    Uterine adenomyosis is a widespread condition that impairs female fertility, with elevated serum levels of cancer antigen 125 (CA125) and prolactin (PRL) often observed in affected women. Mifepristone has been investigated as a potential therapeutic agent to improve pregnancy outcomes in uterine adenomyosis patients. This study aimed to examine the effects of mifepristone on serum CA125 and PRL levels in uterine adenomyosis mouse models. The Institute of Cancer Research (ICR) mice were treated with varying doses of mifepristone after uterine adenomyosis was induced. Immunohistochemistry was used to analyze estrogen receptor and CA125 expression in uterine tissues, while serum CA125 and PRL levels were measured by enzyme-linked immunosorbent assay (ELISA). The study found that mifepristone treatment significantly reduced serum CA125 and PRL levels, and the 20 mg/kg/day dose was most effective in improving pregnancy outcomes. These findings suggest that mifepristone can reduce key biomarkers associated with uterine adenomyosis and improve fertility outcomes, offering a promising treatment option for women suffering from this condition.

  • Potential role of extracellular vesicles from different sources in unexplained recurrent pregnancy loss

    by Yingdan Huang, Liang Ren, Nana Ma, Xiaoqian Fu, Yuehui Du, Bo Liu

    Unexplained recurrent pregnancy loss (URPL) is complex and has unknown etiologies, simultaneously endangering the patient's physical and mental health. Despite significant advancements in shifting from conventional treatments to cell therapy, clinical research and application in cell therapy have been constrained by its immunogenic properties and biosafety. As a new cell–cell communication pathway, extracellular vesicles (EVs) can transfer their bioactive cargos to other cells by endocytosis, ligand-receptor engagement, or direct fusion, thereby executing diverse biological functions both in proximity and across great distances. It is noteworthy that the role of EVs as a cell-free therapy in the form of a drug transporter has garnered increased attention, and some studies have demonstrated EVs involvement in the key pathology of URPL. This review methodically summarizes the functions of EVs from various sources in URPL, including mesenchymal stem cells, placenta, and other sources of EVs. Furthermore, we discuss the significance of EVs as possible diagnostic biomarkers and therapeutic strategies for URPL and the key questions that need to be addressed in future research.

  • Research progress in rodent models of endometriosis

    by Yan Zeng, Fu Hang, Chuyu Peng, Ling Zhao, Shanshan Ou, Liumei Luo, Bo Liu


  • The roles of chromatin regulatory factors in endometriosis

    by Liumei Luo, Ling Zhao, Lanyu Cui, Chuyu Peng, Shanshan Ou, Yan Zeng, Bo Liu

    Purpose Endometriosis is an estrogen-dependent inflammatory disease and one of the most common gynecological diseases in women of reproductive age. The aim of the review was to explore the relationship between the chromatin regulatory factors and endometriosis. Methods By searching for literature on chromatin regulators and endometriosis in PuMed. Finally, 98 documents were selected. Results Chromatin regulators (CRs) are essential epigenetic regulatory factors that can regulate chromatin structure changes and are usually divided into three categories: DNA methylation compounds, histone modification compounds, and chromatin remodeling complexes. Noncoding RNAs are also chromatin regulators and can form heterochromatin by binding to protein complexes. Chromatin regulators cause abnormal gene expression by regulating chromatin structure, thereby affecting the occurrence and development of endometriosis. Conclusion This review summarizes the participation of chromatin regulators in the mechanisms of endometriosis, and these changes in related chromatin regulators provide a comprehensive reference for diagnosis and treatment of endometriosis.


  • Associations between microbial presence in follicular fluid with IVF outcomes: a systematic review and meta-analysis

    by Shanshan Ou, Ming Liao, Lanyu Cui, Yuehui Du, Ling Zhao, Chuyu Peng, Li Jiang, Bo Liu

    Purpose The aim of the study was to synthesize disparate studies to investigate potential impact of microbial presence in FF of infertile women on IVF outcomes. Methods Following preliminary searches to find medical subject heading (MeSH) terms plus free terms, a systematic search was performed in the PubMed, Cochrane Library, Embase, Web of Science, and Clinicaltrials.gov databases from January 10, 2022, to July 5, 2023. Data collected for each study were analyzed using RevMan 5.4 software available on the Cochrane website. Results After correcting for contamination from the vagina, the FFs of 289 women were detected positively by microbial culture and identification, ELISA, and IPA. The pregnancy rate of the FF-positive group was significantly lower than the FF-negative group (19.7% vs. 32.2%) and (OR: 0.57, 95% CI: 0.28–1.14, P=0.11; I2=56%) while the fertilization rate was almost equal (60.0% vs. 62.0%) and (OR: 1.03, 95% CI: 0.88–1.20, P=0.72; I2=0%). Evidence quality was very low. Conclusions The different species of microorganisms in FF of infertile women may have different effects on IVF outcomes. The Lactobacillus spp. may have a positive effect, while other microorganisms may have the opposite effect.


  • Long non-coding RNA TLR8-AS1 induces preeclampsia through increasing TLR8/STAT1 axis

    by Chuyu Peng, Jianbin Zhu, Hong Guo, Ling Zhao, Feifei Wu, Bo Liu

    Objective: Our current study tried to assay the role of long noncoding RNAs (lncRNAs) TLR8-AS1 in regulating preeclampsia. Methods: TLR8-AS1 expression was examined in the clinical placental tissues of preeclampsia patients and the trophoblast cells induced by lipopolysaccharide (LPS). Then, different lentivirus was infected into trophoblast cells to study the role of TLR8-AS1 in cell functions. Furthermore, interactions among TLR8-AS1, signal transducer and activator of transcription 1 (STAT1) and toll-like receptor 8 (TLR8) were determined. A rat model of preeclampsia induced by N(omega)-nitro-L-arginine methyl ester was developed to validate the in-vitro findings. Results: High expression of TLR8-AS1 was detected in placental tissues of preeclampsia patients and LPS-induced trophoblast cells. In addition, overexpression of TLR8-AS1 arrested the proliferation, migration and invasion of trophoblast cells, which was related to the upregulation of TLR8 expression. Mechanistically, TLR8-AS1 recruited STAT1 to bind to the TLR8 promoter region, and thus promoted the transcription of TLR8. Meanwhile, overexpression of TLR8-AS1 was shown to aggravate preeclampsia by elevating TLR8 in vivo. Conclusion: Our study confirmed that TLR8-AS1 aggravated the progression of preeclampsia through increasing the expression of STAT1 and TLR8.


  • G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma restored the ovarian function of aged rats

    by Lifang Yuan, Weiyu Huang, Yin Bi, Saiqiong Chen, Xi Wang, Ting Li, Peiru Wei, Jiebing Du, Ling Zhao, Bo Liu, et al.


  • Construction and Validation of A Novel Predictive Model Based on Chromatin Regulators in Endometrial Cancer

    by Ling Zhao, Chuyu Peng, Haolun Wang, Shanshan Ou, Ting Li, Peiru Wei, Jianbin Zhu, Bo Liu

    Chromatin regulators (CRs) are substantially associated with the prognosis and immunotherapy responses in multiple cancers. However, comprehensive studies related to the prognostic prediction of CRs in endometrial cancer (UCEC) still remains lacking. Therefore, first, we constructed a prognostic model for UCEC associated with 23 CRs using a univariate Cox regression model as well as the glmnet R package. Then, based on the median risk scores, we separated the UCEC sufferers into the high risk set and low risk set, in which the proportion of sufferers with pathological grade G3 and clinical-stage III–IV is higher in the high risk one. Furthermore, we investigated the association of independent prognostic factors, immunotherapy-related scores, GO, KEGG pathways, and drug sensitivity between both groupings. We identified the high risk set tended to have lower IPS, microsatellite instability, and tumor mutational load. GO and KEGG suggested an enrichment of genes related to ribosome biogenesis, RNA processing and metabolism, viral defence, translational regulation, and calmodulin-binding in the high-risk one, while the other one related to cilia movement, microtubule movement, axonal components, and calmodulin-binding. Drug sensitivity assay showed sensitive doxorubicin could be applied to the high-risk patients. All in all, our team successfully built and validated a predictive model for CRs that predicts the overall survival of UCEC patients, which may provide a potential new direction for prognosis prediction and therapeutic target selection for UCEC patients.

  • Prognostic Value and Immunological Role of the Interleukin 24 Gene in Pan-Cancer Using the Kaplan-Meier Plotter and GEPIA by Genomic Data Commons and R Programming Software

    by ChuYu Peng, Ling Zhao, Shengbin Liao, Saiqiong Chen, Yin Bi, Yihua Yang, Aiping Qin, Bo Liu

    There exists an exclusive cytokine and tumor suppressor gene, which is called Interleukin 24 (IL-24), in interleukin 10 (IL-10) family with antitumor and immune-activating properties. However, pan-cancer analysis of IL-24 for identifying survival prognosis and tumor immune infiltration level remains lacking. This study utilized multiple online data analysis approaches, including TIMER, Oncomine, GEPIA and the Kaplan-Meier Plotter, for analyzing the differences in expression level, survival and tumor immune infiltration of IL-24 from a pan-cancer perspective. The expression dissection expounded IL-24 was under conveyed inside brain and prostate cancers, etc., but overexpressed in breast, colorectal and gastric cancers, etc. Also, the survival analysis indicated that IL-24 expression was positively linked to subsisting inside breast carcinoma, sarcoma, and lung adenocarcinoma, and negatively correlated with stomach adenocarcinoma, kidney renal papillary cell carcinoma, and uveal melanoma. Then, we selected breast cancer and stomach adenocarcinoma as representative cancers for further study and investigation.We found that IL-24 is obviously associated with the immune cellular infiltration inside breast tumor and stomach adenocarcinoma, where IL-24 is significantly linked to the CD4+ T cell and CD8+ T cell infiltration inside breast cancer. As to the subtypes of breast cancer, IL-24 is evidently linked to CD8+ T cells, B cells and CD4+ T cells in BRCA-basal and BRCA-luminal subtypes. Furthermore, we discovered that IL-24 expression is negatively associated with the tumor mutation burden (TMB) and that there is a higher survival rate with IL-24 overexpression in breast cancer patients with a low TMB. This finding suggests that IL-24 can be a substantial biomarker to predict prognostic value and evaluation of infiltrated immune constituents in several cancers.